Customised viral vector manufacturing for cell and gene therapy
Who we are
BioViros is a full-service lentivirus producer, offering affordable,
customised viral vectors for cell and gene therapy with world class quality.
New Zealand based
World class quality
BioViros is proudly supported by Bridgewest Ventures NZ LP. Bridgewest Ventures is part of the Bridgewest Group and has a long track record of successfully incubating and launching major global innovation-led companies.
Bridgewest’s deep technology experience is wide-ranging and includes drug discovery and deep research into health technology, with expertise in novel CAR T-cell platforms.
Bridgewest Ventures leverage their extensive connections, international reach, and commercialisation experience to transform innovative opportunities into world-class companies.
Callaghan Innovation - Fostering Innovation in NZ
We are delighted to be part of Callaghan Innovation’s Technology Incubator Programme.
Callaghan Innovation is New Zealand’s innovation agency. It activates innovation and helps businesses grow faster for a better New Zealand. The government agency delivers a range of innovation and R&D services to suit each stage of business growth.
Callaghan Innovation staff, including more than 200 of New Zealand’s leading scientists and engineers, empower innovators by connecting people, opportunities, and networks and providing tailored technical solutions, skills and capability development programmes, and grants co-funding.